Isoprenaline Chlorhydrate Tillomed

Isoprenaline Hydrochloride, the active ingredient in Isoprenaline Chlorhydrate Tillomed, is a non‑selective beta‑adrenergic agonist presented as an injectable solution for intravenous and subcutaneous use. It is employed to increase heart rate and myocardial contractility in bradycardia, to support cardiac output during heart block, and to provide bronchodilation in bronchospasm.

GNH USA supplies Isoprenaline Chlorhydrate Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Isoprenaline Hydrochloride is used in cardiovascular and respiratory conditions where beta‑adrenergic stimulation is required. - Bradycardia: raises heart rate to restore adequate cardiac output. - Heart block: improves conduction through the atrioventricular node. - Cardiac arrest (adjunct): supports circulation during resuscitation efforts. - Bronchospasm / asthma: relaxes airway smooth muscle to relieve breathing difficulty.

Isoprenaline Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Tachycardia: excessive increase in heart rate. - Palpitations: awareness of rapid heartbeat. - Tremor: fine muscle shaking. - Headache: mild to moderate pain. - Nausea: feeling of stomach upset. - Hyperglycemia: elevated blood glucose levels.

Serious or Rare Side Effects: - Arrhythmias: abnormal heart rhythms that can be life‑threatening. - Myocardial ischemia: reduced blood flow to heart muscle. - Severe hypotension: dangerous drop in blood pressure. - Pulmonary edema: fluid accumulation in lungs. - Allergic reactions: rash, itching, or anaphylaxis.

When using Isoprenaline Hydrochloride, clinicians should consider several safety measures. - Cardiac monitoring: observe heart rate and rhythm continuously. - Blood pressure checks: watch for hypertension or hypotension. - Diabetes management: monitor glucose as hyperglycemia may occur. - Thyroid disease: use cautiously in hyperthyroid patients. - Concomitant MAO inhibitors: avoid due to risk of severe hypertension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Isoprenaline Hydrochloride can interact with other medicines, altering its effects or safety profile.

Major Interactions (Avoid): - Beta‑blockers: antagonize therapeutic action, may cause severe bradycardia. - MAO inhibitors: increase risk of hypertensive crisis. - Tricyclic antidepressants: potentiate cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate electrolyte disturbances. - Digoxin: increased risk of arrhythmias. - Anticholinergic agents: additive tachycardia. - Calcium channel blockers: may enhance cardiac effects.